|
|
|
|
In Silico Drug Interaction of Long-acting
Rilpivirine and Cabotegravir With Rifampin
|
|
|
Reported by Jules Levin
CROI 2018 March 4-7 Boston MA
Rajith KR Rajoli1, Paul Curley1, David Back1, Charles Flexner2, Andrew Owen1, Marco Siccardi1
1 -Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK2-Johns Hopkins University School of Medicine and Bloomberg School of Public Health, Baltimore, MD, USA
|
|
|
|
|
|
|